The Spasticity and Movement Disorders IMPACT Initiative: Improving Patient Assessment and Chemodenervation Treatment

Provided by Catalyst Medical Education, LLC and AKH Inc., Advancing Knowledge in Healthcare.

This activity is supported in part by an independent education grant from Allergan, Inc. and Ipsen Biopharmaceuticals, Inc.

Module List

Module 1: The Spasticity and Movement Disorders IMPACT Initiative: Dystonia

Module 2: The Spasticity and Movement Disorders IMPACT Initiative: Spasticity

Module 3: The Spasticity and Movement Disorders IMPACT Initiative: Overview of Treatments for Spasticity and Dystonia

Module 4: The Spasticity and Movement Disorders IMPACT Initiative: An Overview of Botulinum Toxins

Module 5: The Spasticity and Movement Disorders IMPACT Initiative: Guidance